Fact-Checking Serena Williams and Ozempic: What Medication Did She Really Use?
Discover the full story concerning Fact-Checking Serena Williams and Ozempic: What Medication Did She Really Use.
Williams did not merely address weight biology in casual interviews; she turned her experience into an explicit commercial strategy. In late 2024, Williams announced an expansive commercial and advocacy partnership with Ro, the multibillion-dollar direct-to-patient healthcare company known for its dedicated "Ro Body" GLP-1 insurance and supply platform.
Must Read
The collaboration positioned Williams not as a passive patient speaking through anonymous leaks, but as the visible centerpiece of a corporate push to legitimize prescription weight-loss treatments. Ro invested heavily in securing scarce supplies of branded semaglutide and tirzepatide while expanding proprietary coaching services, charging monthly membership fees averaging $99 to $145 plus the retail cost of medication, which frequently tops $1,000 per month without commercial insurance coverage.
Through Ro, Williams challenged the unspoken mandate that celebrities must attribute sudden weight shifts entirely to green juices, infrared saunas, and pilates. By lending her name, image, and cultural authority to a platform that prescribes GLP-1 receptor agonists, Williams effectively commercialized the exact treatment category that critics accused her of concealing.
| Variable | Early Celebrity Wave (2022, 2023) | Current Disclosure Era (2024, 2026) |
|---|---|---|
| Primary Public Narrative | Attributed to extreme calorie restriction, intense exercise, and lymphatic drainage. | Direct acknowledgment of metabolic plateaus and biological limitations. |
| Common Medication Types | Off-label Ozempic prescriptions diverted from diabetes supplies; gray-market compounding. | FDA-indicated Wegovy, Zepbound, and vetted telehealth GLP-1 care pathways. |
| Commercial Posture | Denial, silence, or legal threats over medication inquiries. | Formal equity stakes, paid brand ambassadorships, and direct sponsorship deals. |
| Cultural Framing | Cosmetic shortcut for red-carpet appearances. | Chronic disease intervention, metabolic health, and postpartum management. |
Sarah Jenkins is a veteran tech journalist with over 12 years of experience covering artificial intelligence, mobile innovations, and digital ethics. Her insights have appeared in leading technology publications worldwide.
